{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:45:12Z","timestamp":1770137112726,"version":"3.49.0"},"reference-count":17,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/br.2014.262","type":"journal-article","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T05:19:56Z","timestamp":1395638396000},"page":"517-520","source":"Crossref","is-referenced-by-count":23,"title":["Effects of Tripterygium glycosides on interleukin-17 and CD4+CD25+CD127low regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis"],"prefix":"10.3892","volume":"2","author":[{"given":"WEI","family":"JI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONGGANG","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENG","family":"GAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAJUN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LINGYU","family":"ZHONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,3,24]]},"reference":[{"key":"key20180107141710_b1-br-02-04-0517","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/RHU.0b013e3182863027","article-title":"Etanercept-induced Henoch-Sch\u00f6nlein purpura in a patient with ankylosing spondylitis","volume":"19","author":"Rolle","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"key20180107141710_b2-br-02-04-0517","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"key20180107141710_b3-br-02-04-0517","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(99)03219-5","article-title":"Impact of sex on inheritance of ankylosing spondylitis: a cohort study","volume":"354","author":"Calin","year":"1999","journal-title":"Lancet"},{"key":"key20180107141710_b4-br-02-04-0517","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","article-title":"Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis","volume":"74","author":"Wendling","year":"2007","journal-title":"Joint Bone Spine"},{"key":"key20180107141710_b5-br-02-04-0517","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin Rheumatol"},{"key":"key20180107141710_b6-br-02-04-0517","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00296-009-1085-2","article-title":"Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients","volume":"30","author":"Wang","year":"2010","journal-title":"Rheumatol Int"},{"key":"key20180107141710_b7-br-02-04-0517","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/art.24933","article-title":"Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population","volume":"60","author":"Davidson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key20180107141710_b8-br-02-04-0517","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1744-313X.2011.01067.x","article-title":"Associations of IL-23R polymorphisms with ankylosing spondylitis in East Asian population: a new case-control study and a meta-analysis","volume":"39","author":"Chen","year":"2012","journal-title":"Int J Immunogenet"},{"key":"key20180107141710_b9-br-02-04-0517","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"key":"key20180107141710_b10-br-02-04-0517","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/berh.2002.0243","article-title":"Genetic aspects of ankylosing spondylitis","volume":"16","author":"Khan","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key20180107141710_b11-br-02-04-0517","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1186\/ar793","article-title":"Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28\u2212T cells in ankylosing spondylitis","volume":"5","author":"Duftner","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"key20180107141710_b12-br-02-04-0517","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/ar386","article-title":"Circulating cytotoxic CD8+CD28\u2212T cells in ankylosing spondylitis","volume":"4","author":"Schirmer","year":"2002","journal-title":"Arthritis Res"},{"key":"key20180107141710_b13-br-02-04-0517","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"key20180107141710_b14-br-02-04-0517","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/039463200902200301","article-title":"Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events","volume":"22","author":"Murdaca","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key20180107141710_b15-br-02-04-0517","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20110496","article-title":"IL-17\/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential","volume":"122","author":"Zhu","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"key20180107141710_b16-br-02-04-0517","first-page":"266","article-title":"The study on expression of IL-23 and IL-17 in ankylosing spondylitis","volume":"25","author":"Wang","year":"2009","journal-title":"Chin J Immunol"},{"key":"key20180107141710_b17-br-02-04-0517","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar3257","article-title":"Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+Th\/Treg cell subset imbalance in ankylosing spondylitis","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2014.262\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T09:25:18Z","timestamp":1515317118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2014.262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,24]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,3,24]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/br.2014.262"],"URL":"https:\/\/doi.org\/10.3892\/br.2014.262","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,24]]}}}